Showing results (231-240 of 336) with videos related to
Sort By:
Pageof 34
Deutsche Zahn-, Mund-, Und Kieferheilkunde Mit Zentralblatt|January 1, 1991
Investigation of the PMN chemotaxis in periodontal diseaseG G Zafiropoulos, L Flores-de-Jacoby, J Wirth, et al.Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|August 7, 2020
[Which patient needs controls of laboratory values after elective laparoscopic cholecystectomy?-Can a score help?]L Fischer, G Kolb, C Segendorf, et al.Chirurgie (Heidelberg, Germany)|March 3, 2023
[The clinical importance of the critical view of safety in laparoscopic cholecystectomy]L Fischer, K Halavach, B Huck, et al.Aktuelle Urologie|December 5, 2003
[Impact of tumor size on long-term survival of patients with organ-confined renal cell cancer]A S Merseburger, G Wegener, M Horstmann, et al.Journal of Cancer Research and Clinical Oncology|January 1, 2005
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancerJ Wierecky, C Kollmannsberger, I Boehlke, et al.Oncology Reports|October 18, 2001
Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancerM A Kuczyk, C Bokemeyer, J Hartmann, et al.International Journal of Cancer|December 22, 1999
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG)C Bokemeyer, C Kollmannsberger, A Harstrick, et al.Oncology Reports|October 18, 2001
Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphomaH Dittmann, M Sokler, C Kollmannsberger, et al.Anti-Cancer Drugs|October 19, 2000
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancerC Kollmannsberger, A Gerl, N Schleucher, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II studyA Harstrick, H J Schmoll, H Wilke, et al.Pageof 34